Ha habido 50 transacciones internas recientes registradas para Atrium Therapeutics, Inc. (RNA), incluyendo 17 compras y 29 ventas. El total de compras internas fue valorado en $16.86M y el total de ventas internas en $8.27M.
Internos destacados con actividad reciente incluyen Gallagher Kathleen P., Flanagan W. Michael, Levin Arthur A. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RNA
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-17 |
Gallagher Kathleen P. |
Chief Program Officer |
Venta Informativa |
911 |
$30.24 |
$27.55K |
50,392 |
| 2025-06-11 |
Flanagan W. Michael |
Chief Scientific Officer |
Venta Informativa |
20,000 |
$32.88 |
$657.69K |
80,195 |
| 2025-06-10 |
Levin Arthur A |
Director |
Concesión de RSU |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Boess Carsten |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kaye Edward M. Md |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Wilson Troy Edward |
Director |
Concesión de RSU |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Henig Noreen |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Thompson Tamar |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kim Jean Jinsun |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Skerjanec Simona |
Director |
Concesión de RSU |
6,692 |
- |
- |
6,692 |
| 2025-06-02 |
Gallagher Kathleen P. |
Chief Program Officer |
Ejercicio de Opciones (Venta) |
5,875 |
$16.65 |
$97.82K |
22,596 |
| 2025-05-01 |
Gallagher Kathleen P. |
Chief Program Officer |
Ejercicio de Opciones (Venta) |
5,875 |
$16.65 |
$97.82K |
28,471 |
| 2025-04-01 |
Gallagher Kathleen P. |
Chief Program Officer |
Ejercicio de Opciones (Venta) |
5,546 |
$14.70 |
$81.53K |
13,829 |
| 2025-03-20 |
Maclean Michael F |
Chief Financial Officer |
Venta Informativa |
7,935 |
$31.06 |
$246.42K |
96,720 |
| 2025-03-20 |
Boyce Sarah |
President and CEO |
Venta Informativa |
31,540 |
$31.06 |
$979.56K |
305,871 |
| 2025-03-20 |
Hughes Steven George |
Chief Medical Officer |
Venta Informativa |
9,578 |
$31.06 |
$297.49K |
72,850 |
| 2025-03-20 |
Flanagan W. Michael |
Chief Scientific Officer |
Venta Informativa |
11,780 |
$31.06 |
$365.87K |
80,195 |
| 2025-03-20 |
Mccarthy Teresa |
Chief Human Resources Officer |
Venta Informativa |
7,778 |
$31.06 |
$241.58K |
97,130 |
| 2025-03-11 |
Flanagan W. Michael |
Chief Scientific Officer |
Venta Informativa |
20,000 |
$30.13 |
$602.61K |
91,975 |
| 2025-03-03 |
Gallagher Kathleen P. |
Chief Program Officer |
Ejercicio de Opciones (Venta) |
5,875 |
$14.70 |
$86.36K |
19,375 |
| 2025-02-03 |
Gallagher Kathleen P. |
Chief Program Officer |
Ejercicio de Opciones (Venta) |
5,875 |
$16.65 |
$97.82K |
34,675 |
| 2025-01-22 |
Gallagher Kathleen P. |
Chief Program Officer |
Venta Informativa |
5,629 |
$30.16 |
$169.78K |
50,554 |
| 2025-01-21 |
Levin Arthur A |
Director |
Venta Informativa |
1,872 |
$28.60 |
$53.54K |
12,958 |
| 2025-01-21 |
Maclean Michael F |
Chief Financial Officer |
Venta Informativa |
1,665 |
$28.59 |
$47.61K |
104,655 |
| 2025-01-21 |
Boyce Sarah |
President and CEO |
Venta Informativa |
5,659 |
$28.59 |
$161.82K |
337,411 |
| 2025-01-21 |
Hughes Steven George |
Chief Medical Officer |
Venta Informativa |
2,032 |
$28.59 |
$58.1K |
82,428 |
| 2025-01-21 |
Flanagan W. Michael |
Chief Scientific Officer |
Venta Informativa |
1,812 |
$28.59 |
$51.81K |
91,975 |
| 2025-01-21 |
Mccarthy Teresa |
Chief Human Resources Officer |
Venta Informativa |
1,221 |
$28.60 |
$34.92K |
104,908 |
| 2025-01-21 |
Gallagher Kathleen P. |
Chief Program Officer |
Venta Informativa |
1,817 |
$28.59 |
$51.95K |
56,183 |
| 2025-01-06 |
Maclean Michael F |
Chief Financial Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Moriarty John B |
Chief Legal Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Boyce Sarah |
President and CEO |
Concesión de RSU |
165,000 |
$31.42 |
$5.18M |
165,000 |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
Desconocido |
315,000 |
$9.05 |
$2.85M |
- |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
Desconocido |
84,625 |
$15.96 |
$1.35M |
- |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Flanagan W. Michael |
Chief Scientific Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Mccarthy Teresa |
Chief Human Resources Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
Desconocido |
16,000 |
$44.00 |
$704K |
- |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
Concesión de RSU |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Calderaro Charles Iii |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-01-06 |
Calderaro Charles Iii |
Chief Technical Officer |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2024-12-18 |
Maclean Michael F |
Chief Financial Officer |
Venta Informativa |
11,151 |
$32.66 |
$364.19K |
82,942 |
| 2024-12-18 |
Boyce Sarah |
President and CEO |
Venta Informativa |
31,855 |
$32.66 |
$1.04M |
265,308 |
| 2024-12-18 |
Flanagan W. Michael |
Csto |
Venta Informativa |
12,742 |
$32.66 |
$416.15K |
72,647 |
| 2024-12-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
Venta Informativa |
11,151 |
$32.66 |
$364.19K |
82,867 |
| 2024-12-16 |
Mccarthy Teresa |
Chief Human Resources Officer |
Ejercicio de Opciones (Venta) |
25,000 |
$14.22 |
$355.5K |
57,500 |
| 2024-12-11 |
Flanagan W. Michael |
Csto |
Venta Informativa |
24,000 |
$35.77 |
$858.4K |
85,389 |
| 2024-11-19 |
Levin Arthur A |
Director |
Ejercicio de Opciones (Venta) |
3,323 |
$1.24 |
$4.12K |
- |
| 2024-11-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
Ejercicio de Opciones (Venta) |
25,000 |
$14.22 |
$355.5K |
82,500 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
